Get the latest tech news
Google’s AI Drug Discovery Firm Isomorphic Labs Secures $600M Funding (founded by Demis Hassabis)
/PRNewswire/ -- Isomorphic Labs, an AI-first drug design and development company, today announced it has raised $600 Million in its first external funding...
Isomorphic Labs was founded with the ambition to leverage the power of AI to reimagine and accelerate drug discovery to bring much-needed treatments to millions of patients globally. "We're excited to bring together a top-tier investor group with deep AI and life sciences expertise as we aim to transform this industry through an interdisciplinary approach," said Isomorphic Labs founder and CEO, Sir Demis Hassabis. After witnessing the extraordinary pace of innovation at Isomorphic Labs, we believe their pioneering approach will redefine AI-powered drug discovery," said Dr. Krishna Yeshwant, Managing Partner at GV.
Or read this on r/technology
